Takeda Pharmaceutical Co Ltd ADR (TAK) — Cash Flow Reinvestment Rate
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow Reinvestment Rate of 0.16x as of December 2025, reinvesting $55.93 Billion (capex $42.57 Billion plus investments $-13.37 Billion) from operating cash flow of $360.04 Billion. Check TAK cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Takeda Pharmaceutical Co Ltd ADR Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Takeda Pharmaceutical Co Ltd ADR across 26 annual periods. Explore Takeda Pharmaceutical Co Ltd ADR long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year capital reinvestment analysis for Takeda Pharmaceutical Co Ltd ADR. For live market cap and broader valuation context, see TAK market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | $567.86 Billion | $1.06 Trillion | $200.79 Billion | ▼ -59.3% |
| 2024 | 1.32x | $944.59 Billion | $716.34 Billion | $480.73 Billion | ▲ +3.8% |
| 2023 | 1.27x | $1.24 Trillion | $977.16 Billion | $633.69 Billion | ▲ +271.2% |
| 2022 | 0.34x | $384.16 Billion | $1.12 Trillion | $186.04 Billion | ▲ +15.9% |
| 2021 | 0.30x | $298.48 Billion | $1.01 Trillion | $236.47 Billion | ▼ -61.2% |
| 2020 | 0.76x | $509.83 Billion | $669.75 Billion | $217.71 Billion | ▼ -91.6% |
| 2019 | 9.04x | $2.97 Trillion | $328.48 Billion | $134.11 Billion | ▲ +1441.6% |
| 2018 | 0.59x | $221.60 Billion | $377.85 Billion | $128.26 Billion | ▼ -80.0% |
| 2017 | 2.94x | $767.72 Billion | $261.36 Billion | $112.03 Billion | ▼ -11.8% |
| 2016 | 3.33x | $84.86 Billion | $25.49 Billion | $84.86 Billion | ▲ +452.0% |
| 2015 | 0.60x | $110.06 Billion | $182.52 Billion | $108.72 Billion | ▲ +13.9% |
| 2014 | 0.53x | $78.52 Billion | $148.34 Billion | $78.52 Billion | ▲ +70.1% |
| 2013 | 0.31x | $95.76 Billion | $307.71 Billion | $95.76 Billion | ▲ +69.2% |
| 2012 | 0.18x | $61.90 Billion | $336.57 Billion | $61.90 Billion | ▼ -51.6% |
| 2011 | 0.38x | $124.17 Billion | $326.94 Billion | $124.17 Billion | ▲ +66.5% |
| 2010 | 0.23x | $86.96 Billion | $381.17 Billion | $86.96 Billion | ▲ +88.6% |
| 2009 | 0.12x | $39.46 Billion | $326.27 Billion | $39.46 Billion | ▲ +8.5% |
| 2008 | 0.11x | $32.62 Billion | $292.50 Billion | $32.62 Billion | ▼ -19.9% |
| 2007 | 0.14x | $29.15 Billion | $209.28 Billion | $29.15 Billion | ▲ +62.1% |
| 2006 | 0.09x | $32.09 Billion | $373.57 Billion | $32.09 Billion | ▼ -52.7% |
| 2005 | 0.18x | $53.67 Billion | $295.54 Billion | $53.67 Billion | ▲ +4.3% |
| 2004 | 0.17x | $54.16 Billion | $311.12 Billion | $54.16 Billion | ▲ +37.0% |
| 2003 | 0.13x | $33.48 Billion | $263.45 Billion | $33.48 Billion | ▼ -18.5% |
| 2002 | 0.16x | $37.52 Billion | $240.59 Billion | $37.52 Billion | ▲ +23.1% |
| 2001 | 0.13x | $26.94 Billion | $212.66 Billion | $26.94 Billion | ▼ -43.1% |
| 2000 | 0.22x | $35.42 Billion | $158.96 Billion | $35.42 Billion | — |